[Loco-regional treatments of the metastatic sites for patients with pauci-metastatic cutaneous melanoma (without brain metastasis): French national guidelines].

abstract：:EXPRESSION III was designed to evaluate the information, needs and expectations of patients with ovarian cancer in different European countries. This abstract focuses on specific results from French OC patients. Two hundred and fifty-seven patients filled a 27-item questionnaire during a medical visit. Median age rang...

journal_title：Bulletin du cancer

authors： De Cock L,Kieffer A,Kurtz JE,Joly F,Weber B

更新日期：2015-03-01 00:00:00

abstract：:Information takes a large part of patient's perceptions of the procedure. If the information is adapted, patients tolerate the procedure well. We point out indications and explain the different types of procedure. For infraclinical masses, sonographically guided automated core needle biopsy removes samples. Sonographi...

journal_title：Bulletin du cancer

authors： Barreau B,Tastet S,Lakdja F,Henriquès C,Valentin F,Labat MJ,Dilhuydy MH

更新日期：2005-03-01 00:00:00

abstract：:Melanoma of the female genital tract is a rare location (less than 2% of melanomas all sites combined). These cancers have a very poor prognosis, due to the delay in diagnosis. Vulvar location is about 1% of melanomas then the vaginal location, uterine and ovarian. There is no consensus to date regarding their care, d...

journal_title：Bulletin du cancer

authors： Trone JC,Guy JB,Mery B,Langrand Escure J,Lahmar R,Moncharmont C,Rivoirard R,Semay T,Chauleur C,Collard O,Vignot S,Magné N

更新日期：2014-01-01 00:00:00

abstract：:Androgen deprivation in patients with metastatic prostate cancer produces palliation of symptoms, PSA decrease and tumoral regression in most patients. After a brief period of disease regression lasting 18 to 24 months nearly all pts will progress to androgen independence disease (HRPC) with progressive clinical deter...

journal_title：Bulletin du cancer

authors： Gravis G,Salem N,Bladou F,Viens P

更新日期：2007-07-01 00:00:00

abstract：:Propensity score, an indicator of the propensity to get one treatment among two (or more), is encountered in non randomized studies (prospective or retrospective). It is calculated after the research of predictive factors for treatment attribution, and corresponds to the probability to receive one of the treatments co...

journal_title：Bulletin du cancer

authors： Kwiatkowski F,Slim K,Verrelle P,Chamorey E,Kramar A

更新日期：2007-07-01 00:00:00

abstract：:Patients with advanced cancer often experience with physical impairment and loss of autonomy sometimes preceding inexorable death. It is that can emerge Suicidal ideation occasionally associated with suicidal attempt can arise in this particular context but also following the initial diagnostic talk and during all the...

journal_title：Bulletin du cancer

authors： Lefetz C,Reich M

更新日期：2006-07-01 00:00:00

abstract：:Having to start chemotherapy during pregnancy remains a rare event. The decision to proceed this treatment relies on the drugs used, the time of exposure for the foetus and the gestational age at the time of exposure. As a matter of fact, the mutagenicity potential of the chosen medicine has to be known, and consequen...

journal_title：Bulletin du cancer

authors： Pautier P,Lhomme C,Morice P

更新日期：2002-09-01 00:00:00

abstract：:Apparition of new tools in the therapy of multiple (MM) strengthens the need for valuable prognostic categorization of each patient in order to propose the most adequate treatment. Prognostic factors in MM can be divided in four groups. The first, including beta 2 microglobulin (beta 2m), hemopoiesis impairment, osteo...

journal_title：Bulletin du cancer

authors： Bauduer F,Troussard X,Delmer A

更新日期：1993-12-01 00:00:00

abstract：:This study is devoted to the analysis of the surgical treatment of cancer of the uterine cervix, stage III. Three circumstances are evaluated: - Stage III with urinary disease the purpose of the surgical treatment is most often to save the renal function;--Recurrences after radiotherapy where surgery is the only poss...

journal_title：Bulletin du cancer

authors： Rochard F,Michel G,Castaigne D,Lacour J

更新日期：1980-01-01 00:00:00

abstract：PURPOSE:GemOx was defined as a D1-D2 schedule, based on preclinical data. In order to improve convenience for patients, we evaluated a simplified D1-D1 GemOx regimen (S-GemOx) in MPA. PATIENTS AND METHODS:Patients (pts) with MPA were 2:1 randomly assigned for first-line treatment to S-GemOx (gemcitabine 1,000 mg/m(2),...

journal_title：Bulletin du cancer

authors： Afchain P,Chibaudel B,Lledo G,Selle F,Bengrine-Lefevre L,Nguyen S,Paitel JF,Mineur L,Artru P,André T,Louvet C

更新日期：2009-05-01 00:00:00

abstract：UNLABELLED:Experimental study of rhabdomyosarcoma with successive transplantation upon C3H/He mice, treated by irradiation (Co 60) and combined irradiation-hyperbaric oxygen (HBO), dating from 3, 14 and 15 days after transplantation. The data (tumor volume evolution, histological modifications, pulmonary metastases) ar...

journal_title：Bulletin du cancer

authors： Agnius-Delord C,Couderc P,Laval P,Mourret A,Rinaldi R,Rinaldi C

更新日期：1979-01-01 00:00:00

abstract：:Oncolor, network in oncology in Lorraine, was born ten years ago, from a group of professionals in the field of oncology who worked closed together with regional administrative authorities. Oncolor was created with respect of equilibrium between the different regional partners avoiding struggle for power. Oncolor was ...

journal_title：Bulletin du cancer

authors： Bey P,Bouvier R,David M,Delena G,Garin H,Kessler Y,Klein I,Krakowski I,Lang MP,Leclercq JM,Level MC,Luron R,May I,Nabet M,Ruck S,Sommelet D,Theobald S,Unvois R,Walter S

更新日期：2004-07-01 00:00:00

abstract：:mdm2 (mouse double minute) protein seems lead to p53 inactivation and therefore might potentially play a role in carcinogenesis. We have studied mdm2 gene amplification from 239 primary breast cancer tissues. mdm2 gene was amplified in 10% of cases (25/239). mdm2 amplification was associated with c-erbB2 amplification...

journal_title：Bulletin du cancer

authors： Fontana X,Ferrari P,Abbes M,Monticelli J,Namer M,Bussière F

更新日期：1994-07-01 00:00:00

abstract：:Donor allorecognition of the recipient after hematopoietic transplantation can result in graft-versus-host disease, a potent graft-vs-leukemia effect as well as a graft facilitation effect. Danger signals, host Ag-presenting cells and minor histocompatibility Ag have recently emerged as major determinants of such an a...

journal_title：Bulletin du cancer

authors： Tiberghien P,Robinet E,Ferrand C,Saas P,Hervé P

更新日期：2003-08-01 00:00:00

abstract：:Results from case-control studies and prospective studies suggest that diet is involved in the causation of large bowel cancer either as initiator, promoter or inhibitor of carcinogenesis. Available data are not sufficient to serve as a basis for firm specific dietary advice. In the present situation it is attractive ...

journal_title：Bulletin du cancer

authors： Faivre J,Couillault C,Belghiti C

更新日期：1995-07-01 00:00:00

abstract：:This paper reviewed the 2002 guidelines established by the National Federation of Cancer Centres. A group of experts nominated by the 3 French Societies involved in the treatment of cancer pain (AFSOS, SFAP, SFETD), established new guidelines ratios for morphine switching and/or changing of route of administration, in...

journal_title：Bulletin du cancer

authors： Michenot N,Rostaing S,Baron L,Faure S,Jovenin N,Hubault P,Delorme T,Collin E,Filbet M,Chvetzoff G,Delorme C,Minello C,Magnet M,Ammar D,Krakowski I,Poulain P

更新日期：2018-11-01 00:00:00

abstract：:For two decades, the prognostic of adult patients with ALL was improved based on pediatric-inspired protocols. These approaches based on less myelosuppressive drugs have led to improved response rates, decreased relapse rates, with a benefit in survival observed in patients aged up to 50-60-years-old. Therapeutic inte...

journal_title：Bulletin du cancer

authors： Rabian F,Boissel N

更新日期：2020-09-24 00:00:00

abstract：:The study of mitotic transduction of the signal showed that overexpression of pAkt and reduction in pERK expression would be associated a biological relapse. For tumors T1-3 N0M0 at the high risk of local relapse after prostatectomy, an immediate radiotherapy compared with a differed radiotherapy (at the time of PSA r...

journal_title：Bulletin du cancer

authors： Oudard S,Medioni J,Scotté F,Banu E

更新日期：2005-10-01 00:00:00

abstract：:The immune system plays a dual role against cancer: it prevents tumor cell outgrowth and also sculpts the immunogenicity of the tumor cells. Cancer cells are able to escape from the immune system by inhibiting T lymphocytes activation. New immunotherapies have been developped to target these T lymphocytes activation m...

journal_title：Bulletin du cancer

authors： Ileana E,Champiat S,Soria JC

更新日期：2013-06-01 00:00:00

abstract：:Oral cavity and pharyngeal cancers account for 75% of head and neck cancers and are the fourth most spread cancer in men. Their incidence has decreased since 1980 in men (incidence from 2011 gives 13,930 for lip, oral cavity, pharyngeal and laryngeal carcinomas) but has increased in women, linked to the more recent sm...

journal_title：Bulletin du cancer

authors： Périé S,Meyers M,Mazzaschi O,De Crouy Chanel O,Baujat B,Lacau St Guily J

更新日期：2014-05-01 00:00:00

abstract：:Pain is frequent in the course of cancer and can have negative consequences on patients quality of life. The great majority of patients can be helped by simple treatments. The prescription of morphine (M) must be preceded by some explanations. In order to verify the reality of these explanations, a study was done in a...

journal_title：Bulletin du cancer

authors： Ranchere JY,Delfosse MH,Saltel P,Latour JF

更新日期：1998-04-01 00:00:00

abstract：:Hepatocellular carcinoma is the third most frequent cause of cancer death worldwide, particularly in Asia and Africa. Most cases complicate an underlying liver cirrhosis due to hepatitis B or C chronic virus infection or alcoholic abuse. But, following the current epidemics of obesity and type 2 diabetes, it appears t...

journal_title：Bulletin du cancer

authors： Raoul JL,Raimbourg J,Hiret S,Adhoute X,Senellart H

更新日期：2018-05-01 00:00:00

abstract：:Acute and chronic renal failures are very common after allogeneic HSCT. These complications have a real impact on mortality and morbidity of transplant recipients. Within the framework of the ninth workshops of practice harmonization of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-...

journal_title：Bulletin du cancer

authors： Detrait M,de Berranger E,Dulery R,Ménard AL,Thépot S,Toprak SK,Turlure P,Yakoub-Agha I,Guillaume T

更新日期：2020-01-01 00:00:00

abstract：:Although cytotoxic chemotherapy is the main therapeutic option to treat gastric cancer in the metastatic setting, molecular targeted agents have recently been introduced in an effort to improve survival outcomes which in average do not exceed 1 year. Trastuzumab and ramucirumab, antibodies directed against HER2 and VE...

journal_title：Bulletin du cancer

authors： Bui QL,Grazziotin-Soares D,Hasiniatsy RE,Trinh HS,Richard S,Lotz JP,Gligorov J,Khalil A

更新日期：2018-10-01 00:00:00

abstract：:Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice of hematologic malignancies. Acute graft versus host disease (GvHD) is common after HSCT and directly related to graft versus leukemia effect. Little progress has been done in the treatment of acute GvHD. The first line treatment is u...

journal_title：Bulletin du cancer

authors： Xhaard A,Hermet E,Bay JO,Peffault de Latour R

更新日期：2011-08-01 00:00:00

abstract：:Angiogenesis plays an important role in the progression of tumors. This relationship has been described in several hematologic malignancies. Vascular endothelial growth factor and basic fibroblast growth factor are predictors of poor prognosis in leukemia and non Hodgkin's lymphoma. Bone marrow microvessels were found...

journal_title：Bulletin du cancer

authors： Zini JM,Tobelem G

更新日期：2007-07-01 00:00:00

abstract：:Cytogenetic, molecular and phenotyping features of malignant hematologic diseases succeeded in improving their management by a more accurate stratification of patients according to several groups of risk and by providing a rational for targeted therapy. Three major types of treatment (excluding cellular therapy) are c...

journal_title：Bulletin du cancer

authors： Baleydier F,Domenech C,Thomas X

更新日期：2011-08-01 00:00:00

abstract：:Image guided radiation therapy (IGRT) is a major technical innovation of radiotherapy. It allows locating the tumor under the linear accelerator just before the irradiation, by direct visualization (3D mode soft tissue) or indirect visualization (2D mode and radio-opaque markers). The technical implementation of IGRT ...

journal_title：Bulletin du cancer

authors： Lagrange JL,de Crevoisier R

更新日期：2010-07-01 00:00:00

abstract：INTRODUCTION:French national guidelines lead us to increase the part of one-day breast cancer conservative surgery. Our objective was to check if we can enhance our outpatient part and to identify solutions to improve our practices. METHODS:From 01/01/2013 to 31/12/2014, we conducted a monocentric and retrospective re...

journal_title：Bulletin du cancer

authors： Gachon B,Nadeau C,Fritel X

更新日期：2015-12-01 00:00:00

abstract：:Triple-negative breast cancer (TNBC), as defined by the absence of estrogen and progesterone receptor expression, as well as the lack of HER2 overexpression/amplification, corresponds to 15% of breast cancer and represents an aggressive form of the disease. TNBC are frequently confounded with basal subtype in the mole...

journal_title：Bulletin du cancer

authors： Gonçalves A,Sabatier R,Charafe-Jauffret E,Gilabert M,Provansal M,Tarpin C,Extra JM,Viens P,Bertucci F

更新日期：2013-05-01 00:00:00